<DOC>
	<DOCNO>NCT00507533</DOCNO>
	<brief_summary>The purpose study evaluate use CPAP prevention acute respiratory failure neutropenic ( hematologic malignancy ) patient .CPAP apply preventively hematological patient high risk ARF may reduce : need intubation mechanical ventilation , incidence pneumonia sepsis , mortality , length ICU hospital stay</brief_summary>
	<brief_title>Early Application CPAP Hematologic</brief_title>
	<detailed_description>Immunocompromised patient hematological malignancy require admission intensive care unit ( ICU ) subsequently mechanical ventilation respiratory failure estimate 20- 50 per cent admit hospital . The survival rate patient require mechanical ventilation poor . In many case immunodepression great improvement severe complication infection , pneumonia , sepsis , consequence therapy ( chemotherapy , bone marrow transplantation stem cell transplantation ) . Pneumonia common cause mechanical ventilation 45-74 per cent patient acute respiratory failure ( ARF ) . The trial design enroll 40 patient two group demonstrate reduction 50 % 10 % need mechanical ventilation , type I risk error 5 % power 80 % . Patients randomize treated four day Venturi mask FiO2 0.4 ( control ) oxygen FiO2 0.4 plus CPAP 10 cm H2O ( CPAP ) . At end 4-days period , patient pass screen test breathing ambient air . Patients return assigned treatment SaO2 le 95 % a.a respiratory rate 25 bpm.CPAP generate use flow generator adjustable inspiratory oxygen fraction set deliver flow 140 liter per minute ( Whisperflow , Caradyne , Ireland ) spring-loaded expiratory pressure valve ( Vital Signs Inc , Totoma NJ ) apply use latex-free polyvinyl chloride transparent helmet ( CaStar , Starmed , Italy ) ( 15 ) ; center measure inspiratory oxygen fraction use oxygen analyzer ( Oxicheck , Caradyne , Ireland ) Venturi mask helmet .</detailed_description>
	<mesh_term>Hematologic Diseases</mesh_term>
	<criteria>Neutropenic hematological patient ( less 1000 leukocyte /mm3 ) . SaO2 le 95 % ( a.a. ) , Respiratory rate ( RR ) 25 breaths/minute . NYHA class II III IV unstable angina MI Valvular heart disease cardiac surgery ( previous 3 month ) Implanted cardiac pacemaker BMI le 40 History dilate cardiomyopathy CPE Severe COPD ( oxygen therapy , recent exacerbation , hypoxemichypercapnic resting , FEV1 &lt; 50 % ) Diagnosis sleep neuromuscular disorder . Claustrophobia . Mechanical ventilation criterion : Severe hypoxemia ( arterial oxygen saturation &lt; 80 % maximal FiO2 ) Ph &lt; 7.3 PaCO2 &gt; 50 mmHg Signs patient distress accessory muscle recruitment paradoxal abdomen movement RR &gt; 35 breaths/minute .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>CPAP</keyword>
	<keyword>Hematologic</keyword>
	<keyword>Neutropenic</keyword>
	<keyword>ARF</keyword>
</DOC>